Companies›Fast Moving Consumer Goods›Fast Moving Consumer Goods›Personal Products
NSE:HONASA

HONASA CONSUMER LIMITED

Fast Moving Consumer Goods › Personal Products·NIFTY 500NIFTY MIDSMALLCAP 400NIFTY MIDSMALLCAP400 50:50NIFTY SMALLCAP 250+4
₹449.15
at close · 27 Oct 2026
▲ 5.30 (+1.19%)
ThemesQuick Commerce & E-commerce· growing

Latest filings

Next results: Fri, 6 Nov · Financial Results
  1. Vipul Maheshwari elevated to Chief Product and Technology Officer · Management Changes
  2. Board to approve September quarter and half-year results · Results
  3. Routine compliance filing on share dematerialisation for Q2 FY2026 · Compliance
All filings ↓
Ask Nexa about HONASA CONSUMER LIMITED

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Operates a multi-brand beauty and personal care platform in India, selling topical products directly to consumers through general trade, modern trade and e-commerce channels. The flagship Mamaearth brand, focused on natural and baby care, is sold across 200,000 retail outlets and grew in the mid-teens in FY26. The Derma Co, built around active-ingredient skincare, has reached ₹750 cr+ in annualised revenue with about 1% Nielsen share in the face wash category. Reginald Men, a men's grooming brand consolidated in FY26, doubled its revenue and crossed ₹100 cr in annualised revenue within its first quarter post-acquisition. Focus categories grew 35% year-on-year in FY26, contributing 500 basis points to overall mix. The company has entered nutraceuticals via a 58% stake in Fluence Pharma and added BTM Ventures at a 95% stake. Other operating expenses are the largest line on the cost sheet at 49.3% of revenue, and management has flagged raw and packaging material inflation as a near-term cost pressure addressed through Q1 FY27 calibrated price hikes.

Operating scale
Mamaearth retail outlets
200,000FY26
The Derma Co annualised revenue
₹750 cr+FY26
The Derma Co target ARR
₹1,000 crMedium-term target
Reginald Men annualised revenue
₹100 cr+Q4 FY26
Brands at ₹100 cr+ ARR scale
6FY26
Fluence Pharma dermatologist network
3,000+FY26
Who pays it
Indian consumers purchasing through general trade, modern trade and online (e-commerce) channels
Biggest cost
Raw and packaging materials, flagged as a near-term inflation pressure; other operating expenses are the largest line at 49.3% of revenue
Kind of business
Multi-brand, asset-light Indian beauty and personal care platform
Where it sits
Portfolio of six brands each at ₹100 cr+ ARR scale, with The Derma Co cited as India's largest actives brand (Euromonitor) and ~1% Nielsen share in face wash
Market Cap
₹14,621 Cr
P / E (TTM)
50.4×
EV / EBITDA
32.4×
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
17.8%▲
ROCE (FY26)
ROE 14.2% · margin 13.2%
Leverage
0.00·
Debt / Equity · low
Net cash ₹119 Cr
Revenue FY24→FY26
1.2×▲
Margin +2.6 pts
₹1,920 Cr → ₹2,392 Cr
Cash conversion
1.25×▲
Operating cash ÷ profit · 3 yrs
₹479 Cr on ₹383 Cr
Moves on a normal day
1.28%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 15 Personal Care peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#10/15
P/B#9/13
ROCE#12/16
ROE#9/13
Debt / Equity#1/13
EBITDA margin#10/13
Revenue growth#5/14
Profit growth#2/13

Scorecard

Measured from the filed financials, judged against its Personal Care peers · as of FY26 — not investment advice

Strengths
Over 3 years it reported ₹383 Cr of profit and ₹479 Cr of operating cash — 1.25×
Profit is converting into cash
Negative working-capital cycle — the business is funded by its suppliers
Concerns
Nothing flagged in the filed numbers.

Charts

How has the market priced it — with filings on the timeline?

HONASA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from HONASA CONSUMER LIMITED's filed financials and exchange disclosures

What does HONASA CONSUMER LIMITED do?

HONASA CONSUMER LIMITED is a Personal Products company listed on NSE and BSE, trading under the symbol HONASA.

Is HONASA CONSUMER LIMITED profitable?

Yes. Over the trailing twelve months HONASA CONSUMER LIMITED reported a net profit of ₹291 Cr on revenue of ₹3,148 Cr.

Does HONASA CONSUMER LIMITED pay a dividend?

Not in the latest reported year — HONASA CONSUMER LIMITED's dividend payout for FY26 was nil.

Is HONASA CONSUMER LIMITED debt-free?

Yes. It reported no borrowings on its 31 Mar 2026 balance sheet, and ₹119 Cr of cash.

Is HONASA CONSUMER LIMITED expensive compared with its peers?

On trailing P/E, HONASA CONSUMER LIMITED ranks 10 of 15 in Personal Care — cheaper than 36% of them, against an industry median of 35.7×. This is a position, not a valuation judgement.

How much does the HONASA CONSUMER LIMITED share price move in a day?

On a typical session HONASA CONSUMER LIMITED moves 1.28% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

When are HONASA CONSUMER LIMITED's next results?

Financial Results on Fri, 6 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track HONASA CONSUMER LIMITED's announcements?

Every NSE and BSE filing by HONASA CONSUMER LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.